These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4978602)

  • 41. Immunosuppressive activity of mouse alloantibodies.
    Witz IP; Chiampi NP; Kaliss N
    Transplantation; 1969 Oct; 8(4):516-9. PubMed ID: 5384042
    [No Abstract]   [Full Text] [Related]  

  • 42. Heterologous antilymphocyte serum: differential effect on antigen-sensitive and antibody-producing cells.
    Möller G; Zukoski CF
    Surgery; 1968 Jul; 64(1):39-47. PubMed ID: 5658739
    [No Abstract]   [Full Text] [Related]  

  • 43. Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin.
    Martin WJ; Miller JF
    J Exp Med; 1968 Oct; 128(4):855-74. PubMed ID: 5691988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunity and immunologic tolerance to bacterial antigens. 3. The effect of hydrocortisone and cytotoxic sera on formation of antibodies to Brucella in mice during the neonatal period].
    Kozlov MP; Kulikova GG
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Mar; 47(3):32-7. PubMed ID: 4992806
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunosuppressive effects of anti-lymphocyte serum in complement deficient mice. II. Evidence that activity is mediated by C3 independent antibodies.
    Barth RF; Singla O; Ward PA
    J Immunol; 1974 Feb; 112(2):858-61. PubMed ID: 4205210
    [No Abstract]   [Full Text] [Related]  

  • 46. More immunosuppressives needed.
    Nature; 1969 Mar; 221(5183):805-6. PubMed ID: 5765049
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of anti-thymocyte serum and antilymphocyte serum on the circulating thymic factor and on spontaneous rosette-forming cells of the spleen in mice].
    Del Gobbo V; Garaci C; Garaci E
    Boll Soc Ital Biol Sper; 1976 Aug; 52(15):1199-204. PubMed ID: 1088253
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 49. Selective suppression of cell mediated immunity by equine anti-rabbit lymphocyte serum.
    Stewart PB; Bell R
    Nature; 1970 Jul; 227(5255):279. PubMed ID: 4193612
    [No Abstract]   [Full Text] [Related]  

  • 50. Character of non-precipitating antibodies.
    Christian CL
    Immunology; 1970 Apr; 18(4):457-66. PubMed ID: 4986974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF
    Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract]   [Full Text] [Related]  

  • 52. [Homologous liver transplantation in the dog under immunsuppressive treatment with antilymphocytic serum].
    Pichlmayr R; Mikaéloff P; Messmer K; Rassat JP; Bomel J; Tidow G; Fateh-Moghadam A; Junghans M; Brendel W
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 146(3):261-74. PubMed ID: 4972213
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro demonstration of suppression of the efferent site in transplantation immunity with antilymphocyte serum.
    Tadakuma T; Watanabe S; Mitsuma T; Saito K
    Jpn J Microbiol; 1971 Jan; 15(1):105-8. PubMed ID: 4927837
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolongation of allograft survival with antimacrophage serum.
    Dyminski JW; Argyris BF
    Transplantation; 1969 Nov; 8(5):595-601. PubMed ID: 4928428
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on heterologous antilymphocyte serum in mice. V. Effect of prior administration of normal or antilymphocyte rabbit gamma-globulin.
    Hardy MA; Quint J; Monaco AP
    Transplantation; 1970 May; 9(5):487-96. PubMed ID: 4191803
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytotoxic antibodies after skin allotransplantation in rabbits.
    Matej H
    Arch Immunol Ther Exp (Warsz); 1970; 18(1):29-41. PubMed ID: 4908940
    [No Abstract]   [Full Text] [Related]  

  • 57. Antilymphocyte serum: summary and further observations.
    Woodruff MF
    Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms of immunosuppression by heterologous anti-lymphocyte serum (ALS) and plasma (ALP).
    Jeejeebhoy HF; Rabbat AG; Vela-Martinez JM
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):132-7. PubMed ID: 4913082
    [No Abstract]   [Full Text] [Related]  

  • 59. Separation of anti-inflammatory and immunosuppressive activities in heterologous antilymphocyte serum.
    Perper RJ; Glen EM; Monovich RE
    Nature; 1969 Jul; 223(5201):86-7. PubMed ID: 4893264
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of heterologous antilymphocytic serum on peripheral leukocytes and on the lymphoid organs of BALB-c mice].
    Cerulli L; Cimmino PT; Garaci E
    Riv Biol; 1969; 62(1):75-98. PubMed ID: 4893965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.